Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Cell Therapy
44 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
PAO-03-23-CL-06
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
PR-M02-23-03
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
PAO-01-23-NI-01
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
PAO-12-022-CL-04
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
PAO-11-022-NI-08
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
PR-M11-22-06
iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
PR-M11-22-04
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
PAO-11-022-CL-01
Cell Therapy Manufacturing
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
PR-M08-22-03
Cord Blood
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use
PR-M08-22-02
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
PAO-07-022-CL-03
Contamination Control
Contamination Control Strategies for the Manufacture of Conventional and Next-Generation Biologics
PAO-07-022-CL-07
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
PAO-06-022--NI-06
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
PAO-06-022--NI-04
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
PAO-06-022-CL-03
Cell Therapy
A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape
PAO-05-022-CL-05
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
PAO-05-22-R250-09
Regenerative Medicine
Eliminating Immunosuppression in Regenerative Medicine
PAO-04-22-R250-74
Stem Cells
Delivering Pluripotent Stems Cells Primed to Differentiate
PAO-04-22-R250-71
Mesenchymal Stem Cells
A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion
PAO-04-022-CL-05
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
PR-M04-22-01
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
PR-M03-22-07
Mesenchymal Stem Cells
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
PAO-12-21-NI-01
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
PAO-02-022-CL-12
1
2
»
